India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine
Panacea will then supply the doses to drugmaker Dr Reddy's Laboratories for distribution in India
India's Panacea Biotec Ltd said on Thursday it had agreed to produce up to 25 million doses of the Sputnik V Covid-19 vaccine using the drug substance made by Russia's Generium.
Panacea will then supply the doses to drugmaker Dr. Reddy's Laboratories for distribution in India